These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33847667)

  • 1. Early prediction models for extended-spectrum β-lactamase-producing Escherichia coli infection in emergency department: A protocol for systematic review and meta analysis.
    Zhou Y; Zhang S
    Medicine (Baltimore); 2021 Apr; 100(15):e25504. PubMed ID: 33847667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early prediction models for prognosis of diabetic ketoacidosis in the emergency department: A protocol for systematic review and meta-analysis.
    Li Q; Lv L; Chen Y; Zhou Y
    Medicine (Baltimore); 2021 May; 100(21):e26113. PubMed ID: 34032754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department.
    Lee H; Han SB; Kim JH; Kang S; Durey A
    Am J Emerg Med; 2018 Sep; 36(9):1608-1612. PubMed ID: 29373168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of extended-spectrum β-lactamase and metallo-β-lactamase-producing
    Islam K; Heffernan AJ; Naicker S; Henderson A; Chowdhury MAH; Roberts JA; Sime FB
    Future Microbiol; 2021 May; 16():521-535. PubMed ID: 33960818
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing
    Park SY; Kang CI; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Korean J Intern Med; 2017 Jan; 32(1):146-157. PubMed ID: 27093979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysis.
    Namikawa H; Imoto W; Yamada K; Tochino Y; Kaneko Y; Kakeya H; Shuto T
    J Hosp Infect; 2023 Dec; 142():88-95. PubMed ID: 37802238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for extended-spectrum beta-lactamase-producing Escherichia coli infection in hospitalized patients.
    Ikeda Y; Mamiya T; Nishiyama H; Koseki T; Mouri A; Nabeshima T
    Nagoya J Med Sci; 2012 Feb; 74(1-2):105-14. PubMed ID: 22515116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand.
    Anunnatsiri S; Towiwat P; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1169-77. PubMed ID: 23431823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S; Weber R; Zbinden R; Ruef C; Hasse B
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
    Horie A; Nariai A; Katou F; Abe Y; Saito Y; Koike D; Hirade T; Ito T; Wakuri M; Fukuma A
    Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical risk scoring system for predicting extended-spectrum β-lactamase-producing Escherichia coli infection in hospitalized patients.
    Kengkla K; Charoensuk N; Chaichana M; Puangjan S; Rattanapornsompong T; Choorassamee J; Wilairat P; Saokaew S
    J Hosp Infect; 2016 May; 93(1):49-56. PubMed ID: 26905665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
    Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
    Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands.
    Paltansing S; Vlot JA; Kraakman ME; Mesman R; Bruijning ML; Bernards AT; Visser LG; Veldkamp KE
    Emerg Infect Dis; 2013 Aug; 19(8):1206-13. PubMed ID: 23885972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
    Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016.
    Vock I; Aguilar-Bultet L; Egli A; Tamma PD; Tschudin-Sutter S
    Euro Surveill; 2020 Jul; 25(26):. PubMed ID: 32643598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of extended-spectrum β-lactamase producing Escherichia coli from hospital settings in Yemen.
    Nasher S; Alsharapy S; Al-Madhagi A; Zakham F
    J Infect Dev Ctries; 2018 Nov; 12(11):953-959. PubMed ID: 32012124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.